Access cutting-edge covid-19 treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID-19). The study medicine will be given to patients under 18 years of age with COVID-19 that are not hospitalized but are at risk for
Sponsor: Pfizer
Check if you qualify for this covid-19 clinical trial in Washington Dc, DC
If you're searching for covid-19 treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.